Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC2887986860;86861;86862 chr2:178559497;178559496;178559495chr2:179424224;179424223;179424222
N2AB2723881937;81938;81939 chr2:178559497;178559496;178559495chr2:179424224;179424223;179424222
N2A2631179156;79157;79158 chr2:178559497;178559496;178559495chr2:179424224;179424223;179424222
N2B1981459665;59666;59667 chr2:178559497;178559496;178559495chr2:179424224;179424223;179424222
Novex-11993960040;60041;60042 chr2:178559497;178559496;178559495chr2:179424224;179424223;179424222
Novex-22000660241;60242;60243 chr2:178559497;178559496;178559495chr2:179424224;179424223;179424222
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: N
  • RefSeq wild type transcript codon: AAT
  • RefSeq wild type template codon: TTA
  • Domain: Fn3-98
  • Domain position: 35
  • Structural Position: 37
  • Q(SASA): 0.1186
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
N/K rs1114167328 None 0.156 N 0.423 0.112 0.101711395817 gnomAD-4.0.0 6.84239E-07 None None None None N None 0 0 None 0 0 None 0 0 0 0 1.65662E-05
N/S None None 0.706 N 0.573 0.135 0.117506650769 gnomAD-4.0.0 1.59144E-06 None None None None N None 0 0 None 0 0 None 0 0 0 1.43295E-05 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
N/A 0.3626 ambiguous 0.4699 ambiguous -0.422 Destabilizing 0.504 D 0.692 prob.neutral None None None None N
N/C 0.2513 likely_benign 0.332 benign 0.035 Stabilizing 0.999 D 0.805 deleterious None None None None N
N/D 0.4447 ambiguous 0.5509 ambiguous -1.63 Destabilizing 0.826 D 0.596 neutral N 0.520577744 None None N
N/E 0.7385 likely_pathogenic 0.8459 pathogenic -1.483 Destabilizing 0.913 D 0.601 neutral None None None None N
N/F 0.5305 ambiguous 0.6277 pathogenic -0.193 Destabilizing 0.998 D 0.825 deleterious None None None None N
N/G 0.3228 likely_benign 0.3796 ambiguous -0.78 Destabilizing 0.981 D 0.586 neutral None None None None N
N/H 0.116 likely_benign 0.1523 benign -0.708 Destabilizing 0.138 N 0.42 neutral N 0.484753017 None None N
N/I 0.4693 ambiguous 0.64 pathogenic 0.494 Stabilizing 0.987 D 0.824 deleterious N 0.483903632 None None N
N/K 0.471 ambiguous 0.678 pathogenic -0.217 Destabilizing 0.156 N 0.423 neutral N 0.497911529 None None N
N/L 0.44 ambiguous 0.5795 pathogenic 0.494 Stabilizing 0.967 D 0.78 deleterious None None None None N
N/M 0.438 ambiguous 0.5975 pathogenic 0.909 Stabilizing 1.0 D 0.733 prob.delet. None None None None N
N/P 0.9872 likely_pathogenic 0.991 pathogenic 0.22 Stabilizing 0.978 D 0.757 deleterious None None None None N
N/Q 0.4454 ambiguous 0.5965 pathogenic -0.933 Destabilizing 0.99 D 0.647 neutral None None None None N
N/R 0.4866 ambiguous 0.6399 pathogenic -0.371 Destabilizing 0.975 D 0.622 neutral None None None None N
N/S 0.1304 likely_benign 0.157 benign -0.901 Destabilizing 0.706 D 0.573 neutral N 0.47878705 None None N
N/T 0.249 likely_benign 0.3549 ambiguous -0.587 Destabilizing 0.089 N 0.419 neutral N 0.466506939 None None N
N/V 0.4631 ambiguous 0.6229 pathogenic 0.22 Stabilizing 0.896 D 0.783 deleterious None None None None N
N/W 0.8203 likely_pathogenic 0.8761 pathogenic -0.19 Destabilizing 1.0 D 0.801 deleterious None None None None N
N/Y 0.1614 likely_benign 0.2 benign 0.187 Stabilizing 0.99 D 0.769 deleterious N 0.504858931 None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.